Jay Luly is the President, Chief Executive Officer, and a Director at Enanta Pharmaceuticals.
Jay Luly is the President, Chief Executive Officer, and a Director at Enanta Pharmaceuticals. Enanta Pharmaceuticals is a biotechnology company focused on the discovery and development of small molecule drugs for viral infections and liver diseases. The company's pipeline includes treatments for Hepatitis C Virus, Respiratory Syncytial Virus, SARS-CoV-2, and immunology. Further details regarding funding or Luly's prior background are not provided in the source.
Full founder directory · Investor directory · Company funding database · Fundraising library